Pentetate Calcium Trisodium

CHEMBL1200945 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
497.4 g/mol
LogP
Phase
4

A chelating agent (calcium DTPA) used to treat internal contamination with plutonium, americium, and curium by accelerating their elimination from the body through the urine. It works by forming stable complexes with radioactive heavy metals, facilitating their excretion.

分子量

497.3500 g/mol

TPSA

210.00 Ų

治疗领域

作用机制

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+].[Na+]

InChI

InChI=1S/C14H23N3O10.Ca.3Na/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;;/q;+2;3*+1/p-5

Molecular Formula

C14H18CaN3Na3O10

HBD / HBA

- / 13

可旋转键数

11

重原子数

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A chelating agent (calcium DTPA) used to treat internal contamination with plutonium, americium, and curium by accelerating their elimination from the body through the urine. It works by forming stable complexes with radioactive heavy metals, facilitating their excretion.

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Yes, Pentetate Calcium Trisodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200945. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 25513. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.